Λίστα αντικειμένων
We discussed the recent publication in Blood regarding current guideliens in the managment of AML. These guideliens are imp;lementedd in our policy. Reagrding flt3ITD + AML we aim to participate in a multicenter study with the prophylactic use of a new inhibitor after trasnplantation.
Lecturer: Prof. Spyridonidis
Participants: all medical staff